Anionic surfactants and commercial detergents decrease tight junction barrier integrity in human keratinocytes - 03/09/16
Doi : 10.1016/j.jaci.2016.07.003
Mu Xian, MD, PhD a, b, Paulina Wawrzyniak, MSc a, b, Beate Rückert, Sci Tec a, b, Su Duan, MD, PhD c, d, Yifan Meng, MD a, b, Milena Sokolowska, MD, PhD a, b, Anna Globinska, MSc a, b, f, Luo Zhang, MD, PhD d, e, Mübeccel Akdis, MD, PhD a, b, Cezmi A. Akdis, MD a, b 
a Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland
b Christine Kühne-Center for Allergy Research and Education, Davos, Switzerland
c Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing, China
e Department of Otolaryngology–Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China
d Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China
f Department of Immunology, Rheumatology and Allergy, Medical University of Lodz, Lodz, Poland
| See related article by Liu et al on page 754. |
|
| The authors' laboratories are supported by Swiss National Science Foundation nos. 310030-156823 and 320030-159870, the Christine Kühne-Center for Allergy Research and Education, and Swiss Polish Research Programme PSPB-072/2010. |
|
| Disclosure of potential conflict of interest: M. Xian is an employee of the Department of Otolaryngology–Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China and receives research support from Education and Swiss Polish Research Programme PSPB-072/2010, the Christine Kühne-Center for Allergy Research, the Swiss National Science Foundation (nos. 320030-159870 310030-156823). M. Akdis is an employee of the Swiss Institute of Allergy and Asthma Research, University of Zurich, Switzerland and receives grant support from PREDICTA: European Commission's Seventh Framework programme no. 260895 and the Swiss National Science Foundation. C. A. Akdis serves as a consultant for Actellion, Aventis, Stallergenes, Allergopaharma, and Circacia; is an employee of the Swiss Institute of Allergy and Asthma Research, University of Zurich, Switzerland; and receives grant support from Novartis, PREDICTA: European Commission's Seventh Framework programme no. 260895, MeDALL: European Commission's Seventh Framework programme no. 261357 Research on early initiation of asthma, the Christine Kühne-Center for Allergy Research and Education Research on severe allergies, and the Swiss National Science Foundation. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2016
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 138 - N° 3
P. 890 - septembre 2016 Retour au numéro
Article précédent
- Cesarean section changes neonatal gut colonization
- Jakob Stokholm, Jonathan Thorsen, Bo L. Chawes, Susanne Schjørring, Karen A. Krogfelt, Klaus Bønnelykke, Hans Bisgaard
- The quest for autoreactive antibodies in nasal polyps
- Els De Schryver, Lien Calus, Henryk Bonte, De Ruyck Natalie, Hannah Gould, Erin Donovan, Dirk Elewaut, Rudolf Valenta, Irene Mittermann, Jan Gutermuth, Tanja Seher, Robert P. Schleimer, Bruce K. Tan, Lara Derycke, Thibaut Van Zele, Claus Bachert, Philippe Gevaert
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?